Microcosmos
Computational drug design platformA drug design engine that uses proprietary algorithms and quantum-chemistry-informed simulation, combined with AI, to model protein motion and protein-ligand interaction at atomic resolution. The dynamic behavior data it produces is used to design small molecules with differentiated therapeutic effects and reduced off-target risk.
- Atomic-resolution simulation of protein motion and protein-ligand interactions
- Roughly 10,000x acceleration of protein-dynamics modeling without loss of accuracy
- Quantum chemistry combined with AI-based molecular design
- Lab-in-the-loop experimental feedback into the design cycle
